Skip to content

Mother-infant Signalling During Breastfeeding

Mother-infant Signalling During Breastfeeding: A Randomised Trial Investigating the Effects of a Relaxation Intervention in Breastfeeding Mothers on Breast Milk Production, Breast Milk Cortisol and Infant Behaviour and Growth.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01971216
Acronym
MOMS
Enrollment
64
Registered
2013-10-29
Start date
2013-12-31
Completion date
2017-01-31
Last updated
2018-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breastfeeding Women

Keywords

Breastfeeding, relaxation, anxiety, infant growth

Brief summary

Primary hypotheses 1\. The use of a relaxation tape by breastfeeding mothers that will be given starting at week 2 postpartum, will result in : i) reduced maternal stress and anxiety ii) the production of a higher volume of breast milk iii) lower milk cortisol concentrations iv) favourable effects on infant behaviour (less crying, more sleeping) v) higher milk intake by the infant vi) more optimal growth, specifically higher lean mass and lower fat mass (body composition) Secondary hypotheses (i) Infant temperament/behaviour and gender influence milk and energy intake and hence early growth and body composition (ii) Non-nutrient factors in breast milk (hormones including ghrelin and leptin) influence infant behaviour and feeding patterns and hence infant growth and body composition.

Interventions

BEHAVIORALRelaxation

Sponsors

University College, London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

Primiparous mother with singleton pregnancy Infant is singleton and born at term (37-42 week of gestation) Infant birth weight of \>2500 g (5,5 pounds or 5 pounds and 8,2 ounces) Mother and infant are generally healthy (free of serious illness that can affect breastfeeding or nursing infant, or energy balance of the infant). No current or recent involvement in other research studies that could potentially affect any of outcome measures. Mother speaks and understands either English only or English and Malay (some questionnaires are in English)

Exclusion criteria

Mother or baby has a major illness that affects nursing or breastfeeding, or affects energy balance of the infant. Mother smokes Mothers who do not exclusively breastfeed their infant \-

Design outcomes

Primary

MeasureTime frameDescription
Physiological changes (maternal saliva cortisol, breast milk cortisol and milk volume) before and after physiological-mini test in intervention group at 2,6 and 12 weeks.2,6,12 weeks
Maternal stress and anxietyBaselibne to 12 weeksMaternal stress and anxiety assessed using the Cohen's Perceived Stress Scale (PSS) and Beck Anxiety Inventory (BAI) respectively (change in score from baseline to end-point at 12 weeks)
Breast milk volume at 12 weeks assessed non-invasively using stable isotope techniques12 weeksBreast milk volume at 12 weeks assessed non-invasively using stable isotope techniques
Breast milk cortisol concentrations at 12 weeks12 weeks
Infant behaviour measured using a 3-day diary at 12 weeks12 weeks
Infant weight and body composition measured using stable isotopes at 12 weeks12 weeks

Secondary

MeasureTime frame
Non-nutrient factors in breast milk - leptin and ghrelin2,6,12 weeks
Macronutrient composition of breast milk (fat and protein)2,6,12 weeks

Other

MeasureTime frame
Infant appetite assessed using the BEBQ2,6,12 weeks
Maternal depression assessed using Edinburgh Postnatal Depression Scale (EPDS)2 weeks
Infant temperament measured using the Rothbart questionnaire12 weeks

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026